Citation Impact
Citing Papers
Systematic review and meta-analysis of Transurethral Needle Ablation in symptomatic Benign Prostatic Hyperplasia
2006
Head and neck squamous cell carcinoma
2020 Standout
Clinical update on head and neck cancer: molecular biology and ongoing challenges
2019
Cancer treatment and survivorship statistics, 2022
2022 Standout
From Fly Wings to Targeted Cancer Therapies: A Centennial for Notch Signaling
2014
The independence of intrinsic radiosensitivity as a prognostic factor for patient response to radiotherapy of carcinoma of the cervix
1997
Cancer burden in the year 2000. The global picture
2001 Standout
Environmental and health effects of the herbicide glyphosate
2017 Standout
The epidemiology of urinary tract infection
2010 Standout
Viscoelastic properties of human bladder tumours
2016
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
2017 Standout
Genetics and genomics of radiotherapy toxicity: towards prediction
2011
Pathological changes in human malignant carcinoma treated with high-intensity focused ultrasound
2001
Diagnostic tests and algorithms used in the investigation of haematuria: systematic reviews and economic evaluation
2006
Systematic Review of Complications of Prostate Biopsy
2013
Radiomics: Images Are More than Pictures, They Are Data
2015 Standout
Long Noncoding RNAs in Cancer Pathways
2016 Standout
Effects of extracellular matrix viscoelasticity on cellular behaviour
2020 StandoutNature
Association Between Time to Operation and Pathologic Stage in Ductal Carcinoma in Situ and Early-Stage Hormone Receptor-Positive Breast Cancer
2020
Principles of early drug discovery
2010 Standout
Plasmonic photothermal therapy (PPTT) using gold nanoparticles
2007 Standout
Transurethral Needle Ablation (TUNA<sup>TM</sup>)
1999
EAU Guidelines on Prostate Cancer
2007 Standout
Bladder cancer
2016 Standout
Mouse DNA contamination in human tissue tested for XMRV
2010
Goserelin versus orchiectomy in the treatment of advanced prostate cancer: Final results of a randomized trial
1995
Hypoxia-inducible factors promote breast cancer stem cell specification and maintenance in response to hypoxia or cytotoxic chemotherapy
2018 StandoutNobel
Management of Chronic Kidney Disease Patients in the Intensive Care Unit: Mixing Acute and Chronic Illness
2017 Standout
EAU Guidelines on the Treatment and Follow-up of Non-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction
2013 Standout
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
The molecular landscape of head and neck cancer
2018 Standout
A meta‐analysis of trials of transurethral needle ablation for treating symptomatic benign prostatic hyperplasia
2004
Prevalence of xenotropic murine leukaemia virus-related virus in patients with chronic fatigue syndrome in the Netherlands: retrospective analysis of samples from an established cohort
2010
A Randomized Trial of Radical Radiotherapy for the Management of pT1G3 NXM0 Transitional Cell Carcinoma of the Bladder
2007
Asymptomatic microscopic or dipstick haematuria in adults: which investigations for which patients? A review of the evidence
2002
Role of long noncoding RNAs in malignant disease (Review)
2015
No Evidence for XMRV Nucleic Acids, Infectious Virus or Anti-XMRV Antibodies in Canadian Patients with Chronic Fatigue Syndrome
2011 StandoutNobel
Pyocystis and Prostate Abscess in a Hemodialysis Patient in the Emergency Department
2014
Radiomics: the bridge between medical imaging and personalized medicine
2017 Standout
Adverse Effects of Androgen Deprivation Therapy and Strategies to Mitigate Them
2014 Standout
Global cancer statistics in the year 2000
2001 Standout
Target discovery from data mining approaches
2009
A prospective analysis of the diagnostic yield resulting from the attendance of 4020 patients at a protocol‐driven haematuria clinic
2006
Hypoxia‐inducing factors as master regulators of stemness properties and altered metabolism of cancer‐ and metastasis‐initiating cells
2013
Novel long non-coding RNAs are specific diagnostic and prognostic markers for prostate cancer
2015
Long Noncoding RNA and Cancer: A New Paradigm
2017 Standout
Engineering Multifunctional RNAi Nanomedicine To Concurrently Target Cancer Hallmarks for Combinatorial Therapy
2017
DNA Methylation and Apoptosis Resistance in Cancer Cells
2013
Bladder Cancer
2020 Standout
Dissemination and publication of research findings: an updated review of related biases
2010 Standout
Is transurethral resection of the prostate still justified?
1999
Preliminary Experience Using High Intensity Focused Ultrasound for the Treatment of Patients With Advanced Stage Renal Malignancy
2003
Single-Therapy Androgen Suppression in Men with Advanced Prostate Cancer
2000
The diagnosis, management, treatment and costs of prostate cancer in England and Wales.
1997
Engineering Multifunctional RNAi Nanomedicine To Concurrently Target Cancer Hallmarks for Combinatorial Therapy
2017
TRANSURETHRAL ETHANOL INJECTION THERAPY FOR PROSTATIC HYPERPLASIA: 3-YEAR RESULTS
2004
The diagnostic accuracy and cost-effectiveness of magnetic resonance spectroscopy and enhanced magnetic resonance imaging techniques in aiding the localisation of prostate abnormalities for biopsy: a systematic review and economic evaluation
2013
Chemodynamic Therapy: Tumour Microenvironment‐Mediated Fenton and Fenton‐like Reactions
2018 Standout
Guideline for Management of the Clinical T1 Renal Mass
2009 Standout
Circulation long non-coding RNAs act as biomarkers for predicting tumorigenesis and metastasis in hepatocellular carcinoma
2015
Works of Thomas Lynch being referenced
In silico mining identifies IGFBP3 as a novel target of methylation in prostate cancer
2007
The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS)
2019
Efficacy and safety of peri-prostatic local anaesthetic injection in trans-rectal biopsy of the prostrate: A prospective randomised study
2004
Exposure to hypoxia following irradiation increases radioresistance in prostate cancer cells
2012
Hypoxia, notch signalling, and prostate cancer
2013
Repeat testing for haematuria and underlying urological pathology
1994
High‐intensity focused ultrasound in the treatment of benign prostatic hyperplasia
1997
Rapid diagnostic service for patients with haematuria
1994
Long noncoding RNAs and prostate carcinogenesis: the missing ‘linc’?
2014
In silico analysis and DHPLC screening strategy identifies novel apoptotic gene targets of aberrant promoter hypermethylation in prostate cancer
2010
Transurethral needle ablation of the prostate for the treatment of benign prostatic hyperplasia: a collaborative multicentre study
1997
The defunctionalized bladder
1998
Phase III Randomised Study of Zoladex versus Stilboestrol in the Treatment of Advanced Prostate Cancer
1992
DNA mismatch repair and the DNA damage response to ionizing radiation: Making sense of apparently conflicting data
2010
NO EVIDENCE OF XMRV IN IRISH PROSTATE CANCER PATIENTS WITH THE R462Q MUTATION
2008
A rapid access diagnostic clinic for prostate cancer: the experience after one year
2011
Urologists' Attitudes to the Management of Bladder Cancer
1992
Noncoding RNAs in Prostate Cancer: The Long and the Short of It
2013
Discontinuation of Anticoagulant or Antiplatelet Therapy for Transrectal Ultrasound-Guided Prostate Biopsies: A Single-Center Experience
2012
Local control of T2/3 transitional cell carcinoma of bladder is correlated to differences in DNA supercoiling: evidence for two discrete tumor populations.
1993